Vijaya Diagnostic Centre Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 29.8%
- Latest quarter profit grew 38.4% YoY, showing strong momentum
- Company has delivered good sales growth of 15.8% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.49x)
CONS
- Receivables are growing faster than sales - a possible quality concern
- Stock is trading at 9.4x its book value
- Recurring exceptional / one-off items are inflating headline profit
- Though reporting repeated profits, the company pays out little dividend (11.5%)
- Expensive relative to growth - PEG of 2.8
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8875.00 | 61.07 | 127608.88 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MAXHEALTH | 1039.00 | 69.41 | 101126.94 | 0.19 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| MANIPALHOS | 733.10 | 108.07 | 96430.30 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| FORTIS | 901.80 | 64.97 | 68082.13 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 766.70 | 209.71 | 66831.13 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.26 | 19.53 |
| MEDANTA | 1459.55 | 70.56 | 39243.18 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1909.10 | 47.80 | 39014.52 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| KIMS | 772.75 | 158.86 | 32456.00 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| LALPATHLAB | 1916.70 | 59.37 | 32171.58 | 1.07 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| AGARWALEYE | 505.05 | 107.92 | 16011.41 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1498.50 | 82.32 | 15434.21 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| RAINBOW | 1460.75 | 51.99 | 14836.35 | 0.24 | 62.54 | 16.23 | 469.99 | 33.17 | 28.25 | 28.65 |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119 | 136 | 129 | 141 | 142 | 170 | 158 | 162 | 175 | 189 | 193 | 206 | 219 | |
| 71 | 80 | 78 | 84 | 87 | 100 | 95 | 97 | 105 | 111 | 110 | 115 | 157 | |
| Operating Profit | 47 | 56 | 51 | 57 | 56 | 71 | 63 | 65 | 69 | 79 | 83 | 91 | 62 |
| OPM % | 40.00% | 41.41% | 39.57% | 40.59% | 39.12% | 41.50% | 39.91% | 40.10% | 39.68% | 41.46% | 42.82% | 44.21% | 28.32% |
| 6 | 7 | 3 | 3 | 4 | 5 | 5 | 4 | 7 | 5 | 6 | 7 | 9 | |
| Interest | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 9 | 10 |
| Depreciation | 12 | 14 | 14 | 15 | 15 | 15 | 17 | 17 | 18 | 19 | 21 | 21 | 22 |
| Profit before Tax | 35 | 44 | 34 | 40 | 38 | 54 | 45 | 46 | 52 | 57 | 59 | 68 | 71 |
| Tax % | 25.80% | 24.98% | 25.38% | 23.34% | 24.67% | 26.23% | 24.36% | 26.59% | 25.56% | 25.15% | 25.11% | 22.87% | 25.05% |
| Net Profit | 26 | 33 | 25 | 31 | 29 | 40 | 34 | 33 | 38 | 43 | 44 | 53 | 53 |
| 2.55 | 3.21 | 2.47 | 2.98 | 2.82 | 3.87 | 3.28 | 3.25 | 3.74 | 4.15 | 4.30 | 5.12 | 5.17 |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 279 | 329 | 367 | 451 | 450 | 525 | 634 | 765 | 807 | |
| 187 | 196 | 204 | 251 | 271 | 316 | 379 | 443 | 493 | |
| Operating Profit | 92 | 132 | 163 | 200 | 179 | 209 | 255 | 322 | 314 |
| OPM % | 32.90% | 40.30% | 44.46% | 44.33% | 39.81% | 39.81% | 40.17% | 42.13% | 38.93% |
| 9 | 12 | 11 | 13 | 15 | 23 | 17 | 25 | 27 | |
| Interest | 4 | 15 | 15 | 16 | 21 | 24 | 25 | 31 | 34 |
| Depreciation | 26 | 48 | 50 | 52 | 61 | 55 | 65 | 80 | 84 |
| Profit before Tax | 70 | 82 | 110 | 144 | 111 | 152 | 183 | 236 | 255 |
| Tax % | 30.52% | 25.09% | 24.42% | 25.13% | 25.20% | 24.84% | 25.53% | 24.57% | 24.50% |
| Net Profit | 49 | 61 | 83 | 108 | 83 | 115 | 136 | 178 | 193 |
| EPS | 107.66 | 6.00 | 8.12 | 10.54 | 8.12 | 11.20 | 13.24 | 17.33 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 9.43% | 12.26% | 8.93% | 15.10% | 11.54% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 16%
- 3 Years:
- 19%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 17%
- 3 Years:
- 29%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 47%
- 1 Year:
- 43%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 20%
- 3 Years:
- 20%
- Last Year:
- 21%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 5 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | |
| 209 | 273 | 355 | 458 | 533 | 642 | 754 | 930 | |
| 38 | 149 | 127 | 170 | 233 | 233 | 273 | 379 | |
| Trade Payables | 18 | 19 | 20 | 20 | 27 | 31 | 31 | 35 |
| 22 | 29 | 21 | 44 | 39 | 44 | 153 | 106 | |
| Total Liabilities | 292 | 474 | 527 | 703 | 842 | 960 | 1,221 | 1,460 |
| 137 | 264 | 261 | 353 | 506 | 571 | 673 | 862 | |
| Capital Work in Progress | 3 | 9 | 8 | 34 | 27 | 8 | 67 | 34 |
| 73 | 58 | 33 | 59 | 144 | 254 | 326 | 368 | |
| 2 | 3 | 2 | 4 | 2 | 4 | 4 | 4 | |
| 0 | 0 | 0 | 0 | 0 | 13 | 13 | 21 | |
| Cash & Bank | 52 | 114 | 189 | 186 | 111 | 62 | 42 | 51 |
| 26 | 26 | 35 | 67 | 52 | 48 | 95 | 119 | |
| Total Assets | 292 | 474 | 527 | 703 | 842 | 960 | 1,221 | 1,460 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 95 | 132 | 159 | 195 | 189 | 175 | 208 | 256 | |
| Cash from Investing | -91 | -34 | -129 | -127 | -108 | -139 | -167 | -166 |
| Cash from Financing | 8 | -28 | -48 | -25 | -41 | -43 | -47 | -63 |
| -7 | 46 | -49 | 4 | 13 | -8 | -5 | 27 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-11 - Vijaya Diagnostic Centre Limited has informed the Exchange about General Updates - Investor Presentation - 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam.
2026-09-11 - Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam.".
2026-09-11 - Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026. (Approval for execution of Business Transfer Agreement ("BTA") for 100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on a slump sale basis subject to the fulfilment of Conditions Precedent (CPs) and other terms and conditions as set out in the BTA.
2026-09-02 - Vijaya Diagnostic Centre Limited has informed the Exchange about Schedule of meet
2026-09-02 - Vijaya Diagnostic Centre Limited has informed the Exchange regarding Appointment of Mr Venkata Naresh Yallapragada as Other of the company w.e.f. September 02, 2026.
2026-09-02 - Vijaya Diagnostic Centre Limited has informed the Exchange about change in Management
2026-08-27 - Vijaya Diagnostic Centre Limited has informed the Exchange about Copy of Newspaper Publication
2026-08-26 - Vijaya Diagnostic Centre Limited has informed the Exchange about resignation of Company Secretary/Compliance Officer
2026-08-26 - Vijaya Diagnostic Centre Limited has informed the Exchange regarding Resignation of Mrs. Naga Vasudha Tadepalli as Company Secretary & Compliance Officer of the company w.e.f. August 26, 2026.
News
Recent coverage and analyst commentary for VIJAYA
Loading news…
AI Stock Analyst
Vijaya Diagnostic Centre Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account

